USFDA conducts inspection at Ipca Laboratories’ formulations manufacturing unit at Piparia

27 Apr 2023 Evaluate

The United States Food and Drug Administration (USFDA) has conducted the inspection at Ipca Laboratories’ formulations manufacturing unit situated at Piparia (Silvassa) from April 18, 2023 to April 26, 2023. At the conclusion of the inspection, the USFDA issued a Form 483 with 3 observations.

The company will submit its comprehensive response on these observations to the US FDA within the stipulated time and shall work closely with the agency to resolve these issues at the earliest. 

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.

Ipca Laboratories Share Price

1336.40 8.75 (0.66%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.